When sepsis persists: a review of MRSA bacteraemia salvage therapy

Impact of the Combination of Daptomycin and Trimethoprim-Sulfamethoxazole on Clinical Outcomes in Methicillin-Resistant Staphylococcus aureus Infections

(2015) Kimberly C. Claeys et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in anIn VitroPharmacokinetic/Pharmacodynamic Model

(2015) Katie E. Barber et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial

(2015) Joshua S. Davis et al.   CLINICAL INFECTIOUS DISEASES

Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature

(2015) Sanjiv M. Baxi et al.   INFECTION

Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial

(2015) M. Paul et al.   BMJ-British Medical Journal

Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial

(2015) M. Paul et al.   BMJ-British Medical Journal

Telavancin for refractory methicillin-resistantStaphylococcus aureusbacteremia and infective endocarditis

(2015) Michael A. Ruggero et al.   Infectious Diseases

Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy

(2014) A. M. Casapao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy and Safety of Fosfomycin Plus Imipenem as Rescue Therapy for Complicated Bacteremia and Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: A Multicenter Clinical Trial

(2014) A. del Rio et al.   CLINICAL INFECTIOUS DISEASES

Avoiding the Perfect Storm: The Biologic and Clinical Case for Reevaluating the 7-Day Expectation for Methicillin-Resistant Staphylococcus aureus Bacteremia Before Switching Therapy

(2014) R. Kullar et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline

(2014) George Sakoulas et al.   CLINICAL THERAPEUTICS

Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations

(2014) Joseph A. Paladino et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia

(2014) K. E. Barber et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Salvage treatment of methicillin-resistant staphylococcal endocarditis with ceftaroline: a multicentre observational study

(2014) P. Tattevin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ceftaroline in Combination With Trimethoprim-Sulfamethoxazole for Salvage Therapy of Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis

(2014) Valeria Fabre et al.   Open Forum Infectious Diseases

Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA

(2013) B. J. Werth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

β-Lactam Antibiotics Targeting PBP1 Selectively Enhance Daptomycin Activity against Methicillin-Resistant Staphylococcus aureus

(2013) Andrew D. Berti et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone

(2013) Thomas J. Dilworth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients

(2013) Chung-Chih Lai et al.   BMC INFECTIOUS DISEASES

Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: Case series and review of the literature

(2013) Hari M. Polenakovik et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report

(2013) K. Jongsma et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis

(2013) R. Kullar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus

(2013) George Sakoulas et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Evaluation of the Novel Combination of High-Dose Daptomycin plus Trimethoprim-Sulfamethoxazole against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Using anIn VitroPharmacokinetic/Pharmacodynamic Model of Simulated Endocardial Vegetations

(2012) Molly E. Steed et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Vertebral Osteomyelitis Cases Complicated by Bacteremia Treated with High-Dose Daptomycin and Trimethoprim-Sulfamethoxazole

(2012) Lisa M. Avery et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial Activity

(2012) Warren E. Rose et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Altering the Proclivity towards Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Using Combinations with Other Antibiotics

(2012) Andrew D. Berti et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model

(2012) Brian J. Werth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives

(2012) Shrenik Mehta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Predictors of Mortality in Staphylococcus aureus Bacteremia

(2012) S. J. van Hal et al.   CLINICAL MICROBIOLOGY REVIEWS

Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy

(2012) T. T. Ho et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia

(2012) Hyun Jung Park et al.   JOURNAL OF INFECTION

The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients

(2012) Jennifer C. Lin et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Reduced Susceptibility to Host-Defense Cationic Peptides and Daptomycin Coemerge in Methicillin-Resistant Staphylococcus aureus From Daptomycin-Naive Bacteremic Patients

(2012) N. N. Mishra et al.   JOURNAL OF INFECTIOUS DISEASES

Evaluation of Telavancin Activity versus Daptomycin and Vancomycin against Daptomycin-Nonsusceptible Staphylococcus aureus in anIn VitroPharmacokinetic/Pharmacodynamic Model

(2011) Molly E. Steed et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use of Antistaphylococcal  -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding

(2011) A. Dhand et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study

(2011) Ravina Kullar et al.   PHARMACOTHERAPY

Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations

(2010) M. E. Steed et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-dose daptomycin in documented Staphylococcus aureus infections

(2010) Matteo Bassetti et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae

(2010) H. Moisan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy

(2009) Pamela A Moise et al.   ANNALS OF PHARMACOTHERAPY

Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II

(2009) C. S. Lunde et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety of High‐Dose Intravenous Daptomycin Treatment: Three‐Year Cumulative Experience in a Clinical Program

(2009) D. A. Figueroa et al.   CLINICAL INFECTIOUS DISEASES

Salvage Treatment for Persistent Methicillin‐ResistantStaphylococcus aureusBacteremia: Efficacy of Linezolid With or Without Carbapenem

(2009) Hee‐Chang Jang et al.   CLINICAL INFECTIOUS DISEASES

Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions

(2009) Pamela A Moise et al.   LANCET INFECTIOUS DISEASES

Persistent Staphylococcus aureus bacteremia: Incidence and outcome trends over time

(2008) Riad Khatib et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES